EARLY DIAGNOSIS OF SEPTIC DIC

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Strasbourg, France

About this trial

Disseminated Intravascular Coagulation is a severe complication of septic shock, associated with high mortality, whose diagnosis relies on complex scores that are rarely used in practice. Preliminary studies have shown that increased neutrophil fluorescence is associated with Disseminated Intravascular Coagulation and could reflect NETosis, a key mechanism of immunothrombosis. This study aims to validate neutrophil fluorescence measured on the SthemA 801 analyzer, alone or integrated into an artificial intelligence model, as an early, reliable, and routinely usable biomarker for the diagnosis of septic Disseminated Intravascular Coagulation.

Eligibility criteria

Qualifiers

Male or female ≥ 18 years old

Patient admitted to intensive care for septic shock

Patient affiliated with a social security scheme or having rights

No objection from the patient or a relative in case the patient is not able to express consent, or inclusion under emergency procedure in case the patient is not able to express their opinion and no relative of the patient is reachable.

Disqualifiers

Moribund patient on the day of inclusion

Child-Pugh C cirrhosis

Neutropenia (<500 mm3)

Patient under legal protection

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

492 Participants
are grouped into 1 trial group